Here, we show that betulin, a sterol regulatory element-binding protein 2 (SREBP2) inhibitor, markedly enhances the anti-tumor effect of lenvatinib in HCC bothin vitro andin vivo. The gene discussed is SREBF2; the disease is neoplasm.